The ASSOCIATE study investigators have reported that the I f current inhibitor, ivabradine, is safe, improves exercise performance, and delays the development of ischemia in patients with chronic ...

The Coherent Market Insights has announced the release of a new report titled Angina Pectoris Treatment Market 2022, which provides regional and global market data that is expected to grow in value ...

The goals of treatment are to decrease the frequency of angina, increase longevity, and improve patients' QOL. Management of risk factors is an essential component of this therapy. Also important is ...

Stable angina can be treated with rest or nitrate medications; however, unstable angina is a medical emergency as it can lead to a heart attack. — 123rf Angina pectoris, often shortened to angina, is ...

Most patients with coronary artery disease (CAD) and chronic stable angina will obtain complete relief of symptoms with percutaneous coronary intervention (PCI). However, some chronic angina patients ...

DURING the past two years, interest in the use of vitamin E in the treatment of various forms of heart disease has been aroused by several reports of its efficacy appearing in medical and nonmedical ...

A drug used in the clinical treatment of angina symptoms also has an anti-inflammatory effect and reduces atherosclerotic plaques in blood vessels - thereby reducing the risk of heart attack or stroke ...

Individuals with undetected stable angina pectoris (SAP) as a consequence of undiagnosed coronary artery disease are at high risk of poor quality of life and a premature fatal event (for example, ...

The diagnosed prevalent cases of angina pectoris is expected to increase from 19.58 million cases in 2018 to 22.79 million cases in 2028, at an annual growth rate (AGR) of 1.64% across the seven major ...